A Study to Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection

Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection

NCT03674125 ·Status: COMPLETED ·Phase: PHASE1

A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C

NCT01659567 ·Status: COMPLETED

A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

NCT01225380 ·Status: COMPLETED ·Phase: PHASE2

A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C

NCT01903954 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Pharmacokinetics and Safety of GSK2336805 in Subjects With Hepatic Impairment and Healthy Matched Control Subjects

NCT01827657 ·Status: COMPLETED ·Phase: PHASE1

IdB 1016 Treatment for Hepatitis C Disease

NCT00055445 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Evaluating the Safety of HCV-796 in Subjects With Liver Disease and in Healthy Adults

NCT00314054 ·Status: COMPLETED ·Phase: PHASE1

GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype

NCT01384383 ·Status: TERMINATED ·Phase: PHASE2

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Relapsed Hepatitis C Virus (HCV) Subjects

NCT00142103 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

NCT01740791 ·Status: COMPLETED ·Phase: PHASE1

Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced

NCT00793793 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive

NCT00945880 ·Status: COMPLETED ·Phase: PHASE1

A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy

NCT01058512 ·Status: COMPLETED ·Phase: PHASE2

Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection

NCT02027116 ·Status: COMPLETED ·Phase: PHASE1

Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

NCT00352235 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

NCT01181024 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

NCT00758043 ·Status: COMPLETED ·Phase: PHASE3

Safety, Pharmacokinetics, and Pharmacodynamics of MK-6325 in Hepatitis C Virus (HCV) Infections (MK-6325-003)

NCT01329913 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Peginterferon Lambda-1a vs. Peginterferon Alfa-2a, Plus Ribavirin in Subjects With Genotype 1 Hepatitis C

NCT01754974 ·Status: COMPLETED ·Phase: PHASE3

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

NCT00277238 ·Status: COMPLETED ·Phase: PHASE2

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

NCT01353248 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

NCT00445315 ·Status: COMPLETED ·Phase: PHASE1

A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.

NCT01277692 ·Status: COMPLETED ·Phase: PHASE1

A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection

NCT01803308 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

NCT02185794 ·Status: COMPLETED ·Phase: PHASE1